EUVIMEDEUVIMED entdecken
Crossref

Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus

Zahra Javanmardi, Mahmoud Mahmoudi, Houshang Rafatpanah, Zahra Rezaieyazdi, Abbas Shapouri-Moghaddam, Parisa Ahmadi, Samaneh Mollazadeh, Nafiseh Sadat Tabasi, Seyed-Alireza Esmaeili

Cell Biochemistry and Function · 2024

DOI: 10.1002/cbf.3981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Function, 2024. Verfasst von Zahra Javanmardi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: Lacticaseibacillus rhamnosus, Lactobacillus delbrueckii, Lupus Erythematosus, Systemic, Probiotics. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 89 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic lupus erythematosus (SLE) is known as an autoimmune disorder that is characterized by the breakdown of self‐tolerance, resulting in disease onset and progression. Macrophages have been implicated as a factor in the development of SLE through faulty phagocytosis of dead cells or an imbalanced M1/M2 ratio. The study aimed to investigate the immunomodulatory effects of Lactobacillus delbrueckii and Lactobacillus rhamnosus on M1 and M2 macrophages in new case lupus patients. For this purpose, blood monocytes were collected from lupus patients and healthy people and were cultured for 5 days to produce macrophages. For 48 h, the macrophages were then cocultured with either probiotics or lipopolysaccharides (LPS). Flow cytometry and real‐time polymerase chain reaction were then used to analyze the expression of cluster of differentiation (CD) 14, CD80, and human leukocyte antigen – DR (HLADR) markers, as well as cytokine expression (interleukin [IL]1‐β, IL‐12, tumor necrosis factor α [TNF‐α], IL‐10, and transforming growth factor beta [TGF‐β]). The results indicated three distinct macrophage populations, M0, M1, and M2. In both control and patient‐derived macrophage‐derived monocytes (MDMs), the probiotic groups showed a decrease in CD14, CD80, and HLADR expression compared to the LPS group. This decrease was particularly evident in M0 and M2 macrophages from lupus patients and M1 macrophages from healthy subjects. In addition, the probiotic groups showed increased levels of IL‐10 and TGF‐β and decreased levels of IL‐12, IL1‐β, and TNF‐α in MDMs from both healthy and lupus subjects compared to the LPS groups. Although there was a higher expression of pro‐inflammatory cytokines in lupus patients, there was a higher expression of anti‐inflammatory cytokines in healthy subjects. In general, L. delbrueckii and L. rhamnosus could induce anti‐inflammatory effects on MDMs from both healthy and lupus subjects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lacticaseibacillus rhamnosusLactobacillus delbrueckiiLupus Erythematosus, SystemicProbioticsHumansMonocytesInterleukin-10Tumor Necrosis Factor-alphaLipopolysaccharidesMacrophagesCytokinesAnti-Inflammatory AgentsInterleukin-12Transforming Growth Factor beta

Stichwörter der Autor:innen

Lactobacillus delbrueckiiLactobacillus rhamnosusM0/M1/M2 macrophagesmacrophageprobioticsystemic lupus erythematosus

Substanzen

Interleukin-10Tumor Necrosis Factor-alphaLipopolysaccharidesCytokinesAnti-Inflammatory AgentsInterleukin-12Transforming Growth Factor beta

Autor:innen und Institutionen

  • Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Department, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Immunology Research Centre, Division of Inflammation and Inflammatory Diseases, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Rheumatic Diseases Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.

Förderung

  • Mashhad University of Medical Sciences

Zitieren

APA

Javanmardi, Z., Mahmoudi, M., Rafatpanah, H., Rezaieyazdi, Z., Shapouri-Moghaddam, A., Ahmadi, P., Mollazadeh, S., Tabasi, N. S., & Esmaeili, S. A. (2024). Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochemistry and Function. https://doi.org/10.1002/cbf.3981

Vancouver

Javanmardi Z, Mahmoudi M, Rafatpanah H, Rezaieyazdi Z, Shapouri-Moghaddam A, Ahmadi P, et al. Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus. Cell Biochemistry and Function. 2024. doi:10.1002/cbf.3981

BibTeX
@article{Javanmardi2024,
  author = {Javanmardi, Zahra and Mahmoudi, Mahmoud and Rafatpanah, Houshang and Rezaieyazdi, Zahra and Shapouri-Moghaddam, Abbas and Ahmadi, Parisa and Mollazadeh, Samaneh and Tabasi, Nafiseh Sadat and Esmaeili, Seyed-Alireza},
  title = {Tolerogenic probiotics Lactobacillus delbrueckii and Lactobacillus rhamnosus promote anti‐inflammatory profile of macrophages‐derived monocytes of newly diagnosed patients with systemic lupus erythematosus},
  journal = {Cell Biochemistry and Function},
  year = {2024},
  doi = {10.1002/cbf.3981}
}
Kostenlos starten →